2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SJR(2022): 0.78
Open Access

Health Promot Perspect. 2020;10(2): 98-115. doi: 10.34172/hpp.2020.18
PMID: 32296622        PMCID: PMC7146037

Systematic Review

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

Majid Mobasseri 1 ORCID, Masoud Shirmohammadi 2, Tarlan Amiri 3, Nafiseh Vahed 4,5, Hossein Hosseini Fard 5, Morteza Ghojazadeh 5 * ORCID

Cited by CrossRef: 295

1- Kurtzhals P, Nishimura E, Haahr H, Høeg-Jensen T, Johansson E, Madsen P, Sturis J, Kjeldsen T. Commemorating insulin's centennial: engineering insulin pharmacology towards physiology. Trends in Pharmacological Sciences. 2021;42(8):620 [Crossref]
2- Verhoeff K, Henschke S, Marfil-Garza B, Dadheech N, Shapiro A. Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes. Cells. 2021;10(2):278 [Crossref]
3- Elliott T, Pfotenhauer K. Classification and Diagnosis of Diabetes. Primary Care: Clinics in Office Practice. 2022;49(2):191 [Crossref]
4- Karim R, Vassányi I, Kósa I. Improved Methods for Mid-Term Blood Glucose Level Prediction Using Dietary and Insulin Logs. Medicina. 2021;57(7):676 [Crossref]
5- Van Hulten V, Rasmussen N, Driessen J, Burden A, Kvist A, van den Bergh J. Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature. Curr Osteoporos Rep. 2021;19(6):644 [Crossref]
6- Ganesan S, Tantone R, Komatsu D, Hurst L. The prevalence of Dupuytren’s disease in patients with diabetes mellitus. Commun Med. 2023;3(1) [Crossref]
7- Zolkeflee N, Wong P, Maulidiani M, Ramli N, Azlan A, Mediani A, Tham C, Abas F. Revealing metabolic and biochemical variations via 1H NMR metabolomics in streptozotocin-nicotinamide-induced diabetic rats treated with metformin. Biochemical and Biophysical Research Communications. 2024;708:149778 [Crossref]
8- Ruiz-Grao M, Díez-Fernández A, Mesas A, Martínez-Vizcaíno V, Sequí-Domínguez I, Sebastián-Valles F, Garrido-Miguel M. Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta-Analysis. Pediatric Diabetes. 2024;2024:1 [Crossref]
9- Garcia-Rubio V, Cabrera-Becerra S, Ocampo-Ortega S, Blancas-Napoles C, Sierra-Sánchez V, Romero-Nava R, Gutiérrez-Rojas R, Huang F, Hong E, Villafaña S. siRNA Targeting PDE5A Partially Restores Vascular Damage Due to Type 1 Diabetes in a Streptozotocin-Induced Rat Model. Sci Pharm. 2023;91(4):52 [Crossref]
10- Tanaka S, Akagawa H, Azuma K, Higuchi S, Ujiie A, Hashimoto K, Iwasaki N. High prevalence of copy number variations in the Japanese participants with suspected MODY. Clinical Genetics. 2024; [Crossref]
11- Cruden K, Wilkinson K, Mukaz D, Plante T, Zakai N, Long D, Cushman M, Olson N. Soluble CD14 and Incident Diabetes Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. 2024;8(7) [Crossref]
12- Jensen A, Winther‐Sørensen M, Burisch J, Bergquist A, Ytting H, Gluud L, Wewer Albrechtsen N. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis. Liver International. 2023;43(11):2479 [Crossref]
13- Maffeis C, Mancioppi V, Piona C, Avossa F, Fedeli U, Marigliano M. Type 1 diabetes prevalence and incidence rates in the pediatric population of Veneto Region (Italy) in 2015–2020. Diabetes Research and Clinical Practice. 2021;179:109020 [Crossref]
14- Zhang M, Flores K, Tran H. Deep learning and regression approaches to forecasting blood glucose levels for type 1 diabetes. Biomedical Signal Processing and Control. 2021;69:102923 [Crossref]
15- Schoelwer M, DeBoer M. Artificial Pancreas Technology Offers Hope for Childhood Diabetes. Curr Nutr Rep. 2021;10(1):47 [Crossref]
16- ÇÖVENER ÖZÇELİK Ç, AKTAŞ E. Tip 1 Diyabette Gece Hipoglisemisi “Ebeveynler Önlemeyi Biliyor mu?”: Tanımlayıcı Bir Çalışma. Turk J Diab Obes. 2023;7(1):72 [Crossref]
17- Soomro M, Khan S, Majid A, Bhatti S, Perveen S, Phull A. Pectin as a biofunctional food: comprehensive overview of its therapeutic effects and antidiabetic-associated mechanisms. Discov Appl Sci. 2024;6(6) [Crossref]
18- Pearson J, Wong F, Wen L. Inflammasomes and Type 1 Diabetes. Front Immunol. 2021;12 [Crossref]
19- Verhoeff K, Cuesta-Gomez N, Jasra I, Marfil-Garza B, Dadheech N, Shapiro A. Optimizing Generation of Stem Cell-Derived Islet Cells. Stem Cell Rev and Rep. 2022;18(8):2683 [Crossref]
20- Pinna F, Suprani F, Deiana V, Lai L, Manchia M, Paribello P, Somaini G, Diana E, Nicotra E, Farci F, Ghiani M, Cau R, Tuveri M, Cossu E, Loy E, Crapanzano A, Grassi P, Loviselli A, Velluzzi F, Carpiniello B. Depression in Diabetic Patients: What Is the Link With Eating Disorders? Results of a Study in a Representative Sample of Patients With Type 1 Diabetes. Front Psychiatry. 2022;13 [Crossref]
21- Bensussen A, Santana M, Rodríguez-Jorge O. Metabolic alterations impair differentiation and effector functions of CD8+ T cells. Front Immunol. 2022;13 [Crossref]
22- Muntis F, Smith-Ryan A, Crandell J, Evenson K, Maahs D, Seid M, Shaikh S, Mayer-Davis E. A High Protein Diet Is Associated with Improved Glycemic Control Following Exercise among Adolescents with Type 1 Diabetes. Nutrients. 2023;15(8):1981 [Crossref]
23- Hua W, Hou J, Jiang T, Su B, Fu J, Sun R, Chang B, Xia W, Wu H, Zhang T, Guo C, Wang W. The Longitudinal Association Between Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Adults in China: A Nationally Representative Cohort Study. Front Cardiovasc Med. 2020;7 [Crossref]
24- Niedobylski S, Skarbek M, Tomasik J, Zaręba B, Zawadzka Ż, Próchnicki M, Rudzki G. Eating disorders and carbohydrate metabolism interrelations. 2022;23(2):80 [Crossref]
25- Ferreira M, Neves J, Neves C, Carvalho D. Physical exercise and glycemic management in patients with type 1 diabetes on insulin pump therapy—a cross-sectional study. Acta Diabetol. 2023;60(7):881 [Crossref]
26- Frommer L, Kahaly G. Type 1 diabetes and associated autoimmune diseases. WJD. 2020;11(11):527 [Crossref]
27- Xie J, Chen G, Liang T, Li A, Liu W, Wang Y, Wang X, Kuang X, Han D, Liao W, Song L, Zhang X. Childhood asthma and type 1 diabetes mellitus: A meta‐analysis and bidirectional Mendelian randomization study. Pediatric Allergy Immunology. 2022;33(9) [Crossref]
28- Ghorbani A, Mobasheri L, Moshirian Farahi S, Alavi M, Fakharzadeh Moghaddam O, Nikpasand N, Einafshar E, Esmaeilizadeh M. Type-1 diabetes: Lessons from a decade of preclinical studies on phytotherapy. Fitoterapia. 2024;175:105895 [Crossref]
29- Al Hayek A, Al Dawish M. Patient-Reported Preference and Clinical Efficacy of Insulin Pen Devices With Safety Needles in Adolescents and Young Adults With Type 1 Diabetes: A Prospective Study. 2021; [Crossref]
30- Singh R, Gholipourmalekabadi M, Shafikhani S. Animal models for type 1 and type 2 diabetes: advantages and limitations. Front Endocrinol. 2024;15 [Crossref]
31- Hatipoğlu Ö, Önsüren A, Hatipoğlu F, Kurt A. Caries‐related salivary parameters and oral microbial flora in patients with type 1 diabetes: A meta‐analysis. Diabetes Metabolism Res. 2022;38(5) [Crossref]
32- Travis C, Srivastava P, Hawke T, Kalaitzoglou E, Stratmann B. Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes. Journal of Diabetes Research. 2022;2022:1 [Crossref]
33- Okoduwa S, Abdulwaliyu I. Dietary approach for management of Type-2 diabetes: An overview of glycemic indices of commonly consumed foods in Nigeria. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2023;17(1):102698 [Crossref]
34- Ishaq H, Ibrahim M, Ismail A, Abubaker N, M Elfaki E. Assessment of Specific and Non-specific Autoantibodies among Newly Diagnosed Type 1 Diabetes Mellitus Sudanese Patients. Biomed Pharmacol J. 2022;15(3):1477 [Crossref]
35- Elgamal R, Kudtarkar P, Melton R, Mummey H, Benaglio P, Okino M, Gaulton K. An Integrated Map of Cell Type–Specific Gene Expression in Pancreatic Islets. 2023;72(11):1719 [Crossref]
36- Szabłowski M, Okruszko M, Pochodowicz K, Abramowicz P, Konstantynowicz J, Bossowski A, Głowińska-Olszewska B. Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review. Rheumatol Int. 2022;42(2):371 [Crossref]
37- Pergolizzi J, LeQuang J, Breve F, Magnusson P, Varrassi G. Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review. 2023; [Crossref]
38- Urbonas V, Sadauskaite J, Varnas D. Population-Based Screening for Coeliac Disease in Lithuanian Children from 2009 to 2014. Medicina. 2023;59(9):1630 [Crossref]
39- Mussa B, Venkatachalam T, Srivastava A, Al-Habshi A, Abdelgadir E, Bashier A, Al Awadi F, Hafidh K, Hamoudi R, Abusnana S. Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study. Sci Rep. 2022;12(1) [Crossref]
40- Ebekozien O. The Evolving Landscape of Type 1 Diabetes Management. Endocrinology and Metabolism Clinics of North America. 2024;53(1):xvii [Crossref]
41- Savvopoulos S, Hatzikirou H, Jelinek H. Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease. Biomark�Insights. 2024;19 [Crossref]
42- Mokhtariye A, Dadashi A, Vahidi M, Malekabad E, Yaghoubi Naei V, Khorramnia S. Association of p53 (P72R) gene polymorphism with increased risk of diabetes mellitus in center of Iran (Tehran). Gene Reports. 2021;23:101164 [Crossref]
43- Park Y, Yang C, Cho H. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model. IJMS. 2022;23(13):6877 [Crossref]
44- Varghese R, Krishnamoorthy S, Abdalla H, Baiju A, Borra S. A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications. Braz J Pharm Sci. 2022;58 [Crossref]
45- Fiano K, Singh-Franco D, Kwon Y. Recent Advances in Type 1 Diabetes: Teplizumab (Tzeild®). ADCES in Practice. 2024;12(2):34 [Crossref]
46- Jensen A, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud L, Wewer Albrechtsen N. Autoimmune liver diseases and diabetes. 2023;35(9):938 [Crossref]
47- Campos M, Volpon J, Ximenez J, Franttini A, Dalloul C, Sousa-Neto M, Silva R, Kacena M, Zamarioli A. Vibration therapy as an effective approach to improve bone healing in diabetic rats. Front Endocrinol. 2022;13 [Crossref]
48- Kaptein F, Kiefer B, Cully A, Celiktutan O, Bierman B, Rijgersberg-peters R, Broekens J, Van Vught W, Van Bekkum M, Demiris Y, Neerincx M. A Cloud-based Robot System for Long-term Interaction: Principles, Implementation, Lessons Learned. J Hum-Robot Interact. 2022;11(1):1 [Crossref]
49- AlBurno H, Schneider F, de Vries H, Al Mohannadi D, Mercken L. Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study. F1000Res. 2022;11:907 [Crossref]
50- Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. WJD. 2021;12(7):1010 [Crossref]
51- Nigam S, Bishop J, Hayat H, Quadri T, Hayat H, Wang P. Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics. 2022;14(3):644 [Crossref]
52- Gallach Martínez M, Jara Vidal M, Ruiz de Assín Valverde A, Pinés Corrales P. Prevalence of chronic kidney disease in type 1 diabetes patients. A multicenter study in Castilla-La Mancha, Spain. Revista Clínica Española (English Edition). 2024; [Crossref]
53- Hoft S, Noto C, DiPaolo R. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Front Cell Dev Biol. 2021;9 [Crossref]
54- Daskalopoulou M, Pylli M, Giannakou K. Vitamin D Deficiency as a Possible Cause of Type 1 Diabetes in Children and Adolescents up to 15 Years Old: A Systematic Review. Review of Diabetic Studies. 2022;18(2):58 [Crossref]
55- Räisänen L, Kääriäinen S, Sund R, Engberg E, Viljakainen H, Kolho K. Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case–control study. Pediatr Res. 2023;93(4):1096 [Crossref]
56- Tiselko A, Misharina E, Yarmolinskaya M, Milyutina Y, Zalozniaia I, Korenevsky A. Evaluation of folliculogenesis and oxidative stress parameters in type 1 diabetes mellitus women with different glycemic profiles. Endocrine. 2024; [Crossref]
57- Prasad K, Bhanumathy K. Secoisolariciresinol Diglucoside (SDG) from flaxseed in the prevention and treatment of diabetes mellitus. Scripta Medica. 2023;54(1):87 [Crossref]
58- Onwuakagba I, Okoye E, Kanu F, Kalu C, Akaeme D, Obaji O, Akosile C. Population-based stroke risk profile from a West-African community. eNeurologicalSci. 2023;33:100483 [Crossref]
59- Wang Y, Chen J, Sang T, Chen C, Peng H, Lin X, Zhao Q, Chen S, Eling T, Wang X. NAG-1/GDF15 protects against streptozotocin-induced type 1 diabetes by inhibiting apoptosis, preserving beta-cell function, and suppressing inflammation in pancreatic islets. Molecular and Cellular Endocrinology. 2022;549:111643 [Crossref]
60- Shoaib A, Darraj A, Khan M, Azmi L, Alalwan A, Alamri O, Tabish M, Khan A. A Nanotechnology-Based Approach to Biosensor Application in Current Diabetes Management Practices. Nanomaterials. 2023;13(5):867 [Crossref]
61- Satoh M, Hirose T, Nakayama S, Murakami T, Takabatake K, Asayama K, Imai Y, Ohkubo T, Mori T, Metoki H. Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs. JAHA. 2020;9(16) [Crossref]
62- Karmali R, Sipko J, Majid M, Bruemmer D. Hyperlipidemia and Cardiovascular Disease in People with Type 1 Diabetes: Review of Current Guidelines and Evidence. Curr Cardiol Rep. 2023;25(5):435 [Crossref]
63- Heidari E, Shafiee A, Noorian S, Rafiei M, Abbasi M, Amini M, Safari O, Aghamahdi F, Bakhtiyari M. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials. Diabetes Metabolism Res. 2024;40(4) [Crossref]
64- Alharthi A, Banaganapalli B, Hassan S, Rashidi O, Al-Shehri B, Alaifan M, Alhussaini B, Alsufyani H, Alghamdi K, Nasser K, Bin-Taleb Y, Elango R, Shaik N, Saadah O. Complex Inheritance of Rare Missense Variants in PAK2, TAP2, and PLCL1 Genes in a Consanguineous Arab Family With Multiple Autoimmune Diseases Including Celiac Disease. Front Pediatr. 2022;10 [Crossref]
65- Quattrin T, Mastrandrea L, Walker L. Type 1 diabetes. The Lancet. 2023;401(10394):2149 [Crossref]
66- Nguyen L, Omage J, Noble K, McNew K, Moore D, Aronoff D, Doster R. Group B streptococcal infection of the genitourinary tract in pregnant and non‐pregnant patients with diabetes mellitus: An immunocompromised host or something more?. American J Rep Immunol. 2021;86(6) [Crossref]
67- Yamaguchi M, Honda J, Fukui M. Effects of Parental Involvement on Glycemic Control in Adolescents With Type 1 Diabetes Mellitus: A Scoping Review. J Fam Nurs. 2023;29(4):382 [Crossref]
68- Bass L, Bonami R. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes. Antibodies. 2024;13(2):27 [Crossref]
69- Mohammadi V, Maleki A, Nazari M, Siahmansouri A, Moradi A, Elahi R, Esmaeilzadeh A. Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches. Stem Cell Rev and Rep. 2024;20(3):585 [Crossref]
70- Herstowska M, Przygocka-Pieniążek A, Musiał-Paździor M, Brydziak N. Eating disorders and type 1 diabetes mellitus – case reports. Psychiatr Psychol Klin. 2023;:119 [Crossref]
71- Mansour M, Parizad N, Hemmati Maslakpak M. Does family‐centred education improve treatment adherence, glycosylated haemoglobin and blood glucose level in patients with type 1 diabetes? A randomized clinical trial. Nursing Open. 2023;10(4):2621 [Crossref]
72- Sun X, Rashid M, Askari M, Cinar A. Adaptive personalized prior-knowledge-informed model predictive control for type 1 diabetes. Control Engineering Practice. 2023;131:105386 [Crossref]
73- Wang S, Liao J. Epidemiologic Implication of the Association between Herpes Simplex Virus Infection and the Risk of Type 1 Diabetes Mellitus: A Nationwide Case-Control Study in Taiwan. IJERPH. 2022;19(13):7832 [Crossref]
74- Panwar S, Sarkar P, Kasim D, Anand R, Priya A, Prakash S, Jha S. Portable optical biosensor for point-of-care monitoring of salivary glucose using a paper-based microfluidic strip. Biosensors and Bioelectronics: X. 2024;17:100452 [Crossref]
75- Koca S, Akdogan M, Koca S. Evaluation of early retinal vascular changes by optical coherence tomography angiography in children with type 1 diabetes mellitus without diabetic retinopathy. Int Ophthalmol. 2022;42(2):423 [Crossref]
76- Tzivian L, Sokolovska J, Grike A, Kalcenaua A, Seidmann A, Benis A, Mednis M, Danovska I, Berzins U, Bogdanovs A, Syundyukov E. Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections. Health Qual Life Outcomes. 2022;20(1) [Crossref]
77- Berg A, Svensson J, Thyssen J, Chawes B, Zachariae C, Egeberg A, Thorsen S. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study. Sci Rep. 2023;13(1) [Crossref]
78- Calloni C, Martínez L, Gil D, da Silva D, Jahn M, Salvador M. Jabuticaba [Plinia trunciflora (O. Berg) Kausel] Protects Liver of Diabetic Rats Against Mitochondrial Dysfunction and Oxidative Stress Through the Modulation of SIRT3 Expression. Front Physiol. 2021;12 [Crossref]
79- Khorshidi M, Sayyari A, Olang B, Alaei M, Shab-Bidar S, Khalili M, Salehi M, Aryaeian N. Study protocol of a randomized controlled clinical trial investigating the effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes. Trials. 2021;22(1) [Crossref]
80- Syed F. Type 1 Diabetes Mellitus. Ann Intern Med. 2022;175(3):ITC33 [Crossref]
81- Herranz-Antolín S, Sastre J, Gonzalvo-Díaz C, Del Val-Zaballos F, Moreno-Fernández J, González-López J, Quiroga-López I, López-Gallardo G. Prevalence of autoimmune diseases in patients with type 1 diabetes mellitus. DIACAM 1 study 2010–2020. Medicina Clínica (English Edition). 2022;159(11):522 [Crossref]
82- Wu R, Mumtaz M, Maxwell A, Isaacs S, Laiho J, Rawlinson W, Hyöty H, Craig M, Kim K. Respiratory infections and type 1 diabetes: Potential roles in pathogenesis. Reviews in Medical Virology. 2023;33(2) [Crossref]
83- Min T, Bain S. Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials. Expert Opinion on Emerging Drugs. 2023;28(1):1 [Crossref]
84- Xiang Y, Su B, Liu D, Webber M. Managing Diabetes with Hydrogel Drug Delivery. Advanced Therapeutics. 2024;7(1) [Crossref]
85- Petino Zappala M, Folguera G, Benitez-Vieyra S. Phenotypic decanalization driven by social determinants could explain variance patterns for glycemia in adult urban Argentinian population. Sci Rep. 2022;12(1) [Crossref]
86- Jayasinghe M, Prathiraja O, Perera P, Jena R, Silva M, Weerawarna P, Singhal M, Kayani A, Karnakoti S, Jain S. The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes . 2022; [Crossref]
87- Toren E, Burnette K, Banerjee R, Hunter C, Tse H. Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis. Front Immunol. 2021;12 [Crossref]
88- Ojo O, Grant S, Amanze J, Oni A, Ojo A, Elebiyo T, Obafemi T, Ayokunle D, Ogunlakin A, Singh A. Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic β-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes. PLoS ONE. 2022;17(10):e0276984 [Crossref]
89- Dallagiacoma G, Allora A, Salvati S, Cocciolo G, Capraro M, Lamberti A, Senatore S, Gentile L, Gianfredi V, Laurenzi A, Molinari C, Caretto A, Faccini M, Signorelli C, Scavini M, Odone A. Type 1 Diabetes Patients’ Practice, Knowledge and Attitudes towards Influenza Immunization. Vaccines. 2021;9(7):707 [Crossref]
90- Zhang S, Deng F, Chen J, Chen F, Wu Z, Li L, Hou K. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review. Front Cell Infect Microbiol. 2022;12 [Crossref]
91- Lawand P, Desai S. Nanobiotechnology-Modified Cellular and Molecular Therapy as a Novel Approach for Autoimmune Diabetes Management. PNT. 2022;10(4):279 [Crossref]
92- Desoye G, Ringholm L, Damm P, Mathiesen E, van Poppel M. Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?. Diabetologia. 2023;66(1):33 [Crossref]
93- Cattaneo C, Mameli C, D'Auria E, Zuccotti G, Pagliarini E. The Influence of Common Noncommunicable Diseases on Chemosensory Perception and Clinical Implications in Children and Adolescents. Advances in Nutrition. 2022;13(1):234 [Crossref]
94- Mertens J, De Block C, Spinhoven M, Driessen A, Francque S, Kwanten W. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Front Pharmacol. 2021;12 [Crossref]
95- Penfornis A, Down S, Seignez A, Vives A, Bonnemaire M, Kulzer B. European Survey on Adult People With Type 1 Diabetes and Their Caregivers: Insights Into Perceptions of Technology. J Diabetes Sci Technol. 2023; [Crossref]
96- Mone K, Lasrado N, Sur M, Reddy J. Vaccines against Group B Coxsackieviruses and Their Importance. Vaccines. 2023;11(2):274 [Crossref]
97- Seget S, Włodarczyk J, Lutogniewska W, Rusak E, Dróżdż M, Jarosz-Chobot P. The Use of a Hybrid Closed-Loop System for Glycemic Control in Two Pediatric Patients with Type 1 Diabetes Undergoing Minor Surgery. Healthcare. 2023;11(4):587 [Crossref]
98- Wolkowicz K, Aiello E, Vargas E, Teymourian H, Tehrani F, Wang J, Pinsker J, Doyle F, Patti M, Laffel L, Dassau E. A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control. Bioengineering & Transla Med. 2021;6(2) [Crossref]
99- Tampe I, Garfias C, Borzutzky A, Slaibe L, García H. Incidence of type 1 diabetes in Chilean children between 2006 and 2021: significant increase during the COVID-19 pandemic. Acta Diabetol. 2023;61(1):29 [Crossref]
100- Berney T, Wassmer C, Lebreton F, Bellofatto K, Fonseca L, Bignard J, Hanna R, Peloso A, Berishvili E. From islet of Langerhans transplantation to the bioartificial pancreas. La Presse Médicale. 2022;51(4):104139 [Crossref]
101- Gallach Martínez M, Jara Vidal M, Ruiz de Assín Valverde A, Pinés Corrales P. Prevalencia de enfermedad renal crónica en personas con diabetes tipo 1. Estudio multicéntrico en Castilla-La Mancha, España. Revista Clínica Española. 2024;224(2):119 [Crossref]
102- Serata E, Noonan E, Petersen K, Baig M. Barriers to USMLE Step-1 accommodations: Students with Type 1 Diabetes. PLoS ONE. 2024;19(6):e0304784 [Crossref]
103- Abugoukh T, Al Sharaby A, Elshaikh A, Joda M, Madni A, Ahmed I, Abdalla R, Ahmed K, Elazrag S, Abdelrahman N. Does Vitamin D Have a Role in Diabetes?. 2022; [Crossref]
104- Reutrakul S, Irsheed G, Park M, Steffen A, Burke L, Pratuangtham S, Baron K, Duffecy J, Perez R, Quinn L, Withington M, Saleh A, Loiacono B, Mihailescu D, Martyn-Nemeth P. Association between sleep variability and time in range of glucose levels in patients with type 1 diabetes: Cross-sectional study. Sleep Health. 2023;9(6):968 [Crossref]
105- Oliveira G, Alessi J, Erthal I, Teixeira J, Morello M, Ribeiro R, Telo G, Schaan B, Telo G. Healthy lifestyle gone bad: effect of the COVID-19 pandemic on the daily habits of children and adolescents with type 1 diabetes. 2022; [Crossref]
106- Zimmer R, Auth A, Schierbauer J, Haupt S, Wachsmuth N, Zimmermann P, Voit T, Battelino T, Sourij H, Moser O. (Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise. Diabetes Technology & Therapeutics. 2023; [Crossref]
107- Sachdeva P, M. A, Shukla R, Sahani A. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus. Journal of Medical Engineering & Technology. 2022;46(8):693 [Crossref]
108- Kabir M, Ferdous Mitu J, Akter R, Akhtar M, Saleem A, Al-Harrasi A, Bhatia S, Rahman M, Damiri F, Berrada M, Rahman M. Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environ Sci Pollut Res. 2022;29(31):46385 [Crossref]
109- Galiyeva D, Gusmanov A, Sakko Y, Issanov A, Atageldiyeva K, Kadyrzhanuly K, Nurpeissova A, Rakhimzhanova M, Durmanova A, Sarria-Santamera A, Gaipov A. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019. BMC Endocr Disord. 2022;22(1) [Crossref]
110- Liu Y, Liao Y, Chen V, Chen Y. Association Between Maternal Mood Disorders and Schizophrenia and the Risk of Type 1 Diabetes in Offspring: A Nationwide Cohort Study. NDT. 2023;Volume 19:2511 [Crossref]
111- Fazekas-Pongor V, Svébis M, Major D, Pártos K, Dósa N, Mészáros Á, Horváth V, Domján B, Zsirai L, Tabák A. Trend of pregnancy outcomes in type 1 diabetes compared to control women: a register-based analysis in 1996-2018. Front Endocrinol. 2023;14 [Crossref]
112- Portincasa P, Bonfrate L, Wang D, Frühbeck G, Garruti G, Di Ciaula A. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract. Eur J Clin Investigation. 2022;52(11) [Crossref]
113- Affan M, Dar M. Donislecel-the first approved pancreatic islet cell therapy medication for type 1 diabetes: a letter to the editor. Ir J Med Sci. 2024;193(1):231 [Crossref]
114- Al-Rawahi M, Alsaffar H. Knowledge and Confidence of Omani Pediatric Residents in Managing Diabetic Ketoacidosis: A Cross-Sectional Survey. Journal of Diabetes and Endocrine Practice. 2023;06(03):134 [Crossref]
115- Herranz-Antolín S, Sastre J, Gonzalvo-Díaz C, Del Val-Zaballos F, Moreno-Fernández J, González-López J, Quiroga-López I, López-Gallardo G. Prevalencia de enfermedades autoinmunes en pacientes con diabetes mellitus tipo 1. Estudio DIACAM 1 2010-2020. Medicina Clínica. 2022;159(11):522 [Crossref]
116- Berezin A, Berezin A, Lichtenauer M. Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus. Front Cardiovasc Med. 2020;7 [Crossref]
117- Rittiphairoj T, Owais M, Ward Z, Reddy C, Yeh J, Atun R. Incidence and prevalence of type 1 diabetes and diabetic ketoacidosis in children and adolescents (0–19 years) in Thailand (2015–2020): A nationwide population-based study. The Lancet Regional Health - Western Pacific. 2022;21:100392 [Crossref]
118- Noaro G, Zhu T, Cappon G, Facchinetti A, Georgiou P. A Personalized and Adaptive Insulin Bolus Calculator Based on Double Deep Q- Learning to Improve Type 1 Diabetes Management. IEEE J Biomed Health Inform. 2023;27(5):2536 [Crossref]
119- UYSAL YAZİCİ M, OZEL E, TORUN E, SAVAŞ ERDEVE Ş, ÇETİNKAYA S. Vitamin D Level of Children with Diabetic Ketoacidosis in Pediatric Intensive Care Unit. 2023;33(5):523 [Crossref]
120- Kelly B. Nursing interventions for people with type 1 diabetes and frequent hypoglycaemia. Br J Community Nurs. 2021;26(11):544 [Crossref]
121- Zajec A, Trebušak Podkrajšek K, Tesovnik T, Šket R, Čugalj Kern B, Jenko Bizjan B, Šmigoc Schweiger D, Battelino T, Kovač J. Pathogenesis of Type 1 Diabetes: Established Facts and New Insights. Genes. 2022;13(4):706 [Crossref]
122- Kunath B, Hickl O, Queirós P, Martin-Gallausiaux C, Lebrun L, Halder R, Laczny C, Schmidt T, Hayward M, Becher D, Heintz-Buschart A, de Beaufort C, Bork P, May P, Wilmes P. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses. Microbiome. 2022;10(1) [Crossref]
123- Govindarajan S, Zamir I, Bagewadi S, Moore E. Manifestation of glucose-6-phosphate dehydrogenase deficiency in the wake of new-onset type 1 diabetes mellitus: a case report. J Med Case Reports. 2022;16(1) [Crossref]
124- Giannella L, Grelloni C, Quintili D, Fiorelli A, Montironi R, Alia S, Delli Carpini G, Di Giuseppe J, Vignini A, Ciavattini A. Microbiome Changes in Pregnancy Disorders. Antioxidants. 2023;12(2):463 [Crossref]
125- Walker S, Appari M, Forbes S. Considerations and challenges of islet transplantation and future therapies on the horizon. American Journal of Physiology-Endocrinology and Metabolism. 2022;322(2):E109 [Crossref]
126- Podichetty J, Lang P, O’Doherty I, David S, Muse R, Karpen S, Song L, Romero K, Burton J. Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies. Clin Pharma and Therapeutics. 2022;111(5):1133 [Crossref]
127- Houben J, Janssens M, Winkler C, Besser R, Dzygalo K, Fehn A, Hommel A, Lange K, Elding Larsson H, Lundgren M, Roloff F, Snape M, Szypowska A, Weiss A, Zapardiel‐Gonzalo J, Zubizarreta N, Ziegler A, Casteels K. The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT ‐study . Pediatric Diabetes. 2022;23(8):1707 [Crossref]
128- Joy S, Abraham S, Madiraju G, Almugla Y, Aorrju R. Cytomorphometric Analysis of Exfoliated Buccal Mucosal Cells and DNA Repair Proficiency in Peripheral Lymphocytes in Type 1 Diabetes Mellitus. 2023;15(Suppl 1):S529 [Crossref]
129- Chen K, Zhang Y, Ye P, Gao X, Song L, Zhou H, Li Q, Zhao F, Shi J, Yang X, Shen K, Feng S, Zhao W. Pharmacokinetics and bioavailability of a new long-acting insulin analog in healthy Chinese volunteers: an open, randomized, single-dose, two-period and two-sequence cross-over study. Front Pharmacol. 2023;14 [Crossref]
130- AlBurno H, Schneider F, de Vries H, Al Mohannadi D, Mercken L. Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study. F1000Res. 2024;11:907 [Crossref]
131- Khandagale S, Kamble V, Oza C, Bhor S, Khadilkar A, Khare S. Surrogate markers of metabolic syndrome and insulin resistance in children and young adults with type 1 diabetes: a systematic review & meta-analysis (MetS and IR in T1DM). Int J Diabetes Dev Ctries. 2023; [Crossref]
132- Ghazy A. Role of HLA-DPrs3077 and HLA-DQrs3920 Polymorphisms as Risk Factors for Type 1 Diabetes Mellitus. EMIDDT. 2023;23(6):850 [Crossref]
133- Hebbar P, Nizam R, John S, Antony D, Dashti M, Channanath A, Shaltout A, Al-Khandari H, Koistinen H, Tuomilehto J, Alsmadi O, Thanaraj T, Al-Mulla F. Linkage analysis using whole exome sequencing data implicates SLC17A1, SLC17A3, TATDN2 and TMEM131L in type 1 diabetes in Kuwaiti families. Sci Rep. 2023;13(1) [Crossref]
134- Akhlaghipour I, Bina A, Mogharrabi M, Fanoodi A, Ebrahimian A, Khojasteh Kaffash S, Babazadeh Baghan A, Khorashadizadeh M, Taghehchian N, Moghbeli M. Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population. Hum Genomics. 2022;16(1) [Crossref]
135- El-kady A, Alzahrani A, Elshazly H, Alshehri E, Wakid M, Gattan H, Al-Megrin W, Alfaifi M, Mohamed K, Alharbi W, Elshabrawy H, Younis S. Pancreatic Pathological Changes in Murine Toxoplasmosis and Possible Association with Diabetes Mellitus. Biomedicines. 2022;11(1):18 [Crossref]
136- Dragoun Kolibová S, Wölfel E, Hemmatian H, Milovanovic P, Mushumba H, Wulff B, Neidhardt M, Püschel K, Failla A, Vlug A, Schlaefer A, Ondruschka B, Amling M, Hofbauer L, Rauner M, Busse B, Jähn-Rickert K. Osteocyte apoptosis and cellular micropetrosis signify skeletal aging in type 1 diabetes. Acta Biomaterialia. 2023;162:254 [Crossref]
137- Kjeldsen T, Andersen A, Hubálek F, Johansson E, Kreiner F, Schluckebier G, Kurtzhals P. Molecular engineering of insulin for recombinant expression in yeast. Trends in Biotechnology. 2024;42(4):464 [Crossref]
138- McFadden N, Wilkerson A, Jaiswal J, Chaney B, Stellefson M, Carmack H, Lovett K. Disease Management Experiences among College Students with Type 1 Diabetes: A Qualitative Study. American Journal of Health Education. 2024;:1 [Crossref]
139- Koltuntseva I, Novikova V, Revnova M, Gaiduk I, Khavkin A. Autoimmune gastritis in children with type I diabetes mellitus. jour. 2022;(6):27 [Crossref]
140- van Straalen J, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-del-Castillo Bermejo P, Zulian F, Civino A, Montin D, Wulffraat N, Ruperto N, Swart J. Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry. Pediatr Rheumatol. 2022;20(1) [Crossref]
141- Verhoeff K, Marfil-Garza B, Shapiro A. Update on islet cell transplantation. 2021;26(4):397 [Crossref]
142- Liu H, Sridhar V, Perkins B, Rosenstock J, Cherney D. SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis. Curr Diab Rep. 2022;22(7):317 [Crossref]
143- dos Santos E, Bezerra F, da Silva L, da Silva M, Ferreira O, da Silva Martins L, de Jesus Chaves-Neto A, de Santana Botelho A, Kumar R, Bargali P, do Socorro de Souza Vilhena K, de Aguiar Andrade E, de Oliveira M. Exploring the Potential of Myrcia Genus Essential Oils: A Review of Biological Activities and Recent Advances. Molecules. 2024;29(12):2720 [Crossref]
144- Behera P, Kumar N, Kumari M, Kumar S, Mondal P, Arun R. Integrated microfluidic devices for point-of-care detection of bio-analytes and disease. Sens Diagn. 2023;2(6):1437 [Crossref]
145- Kelaini S, Chan C, Cornelius V, Margariti A. RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease. Biology. 2021;10(5):366 [Crossref]
146- Nemčić M, Shkunnikova S, Kifer D, Plavša B, Vučić Lovrenčić M, Morahan G, Duvnjak L, Pociot F, Gornik O. N-glycosylation of immunoglobulin A in children and adults with type 1 diabetes mellitus. Heliyon. 2024;10(9):e30529 [Crossref]
147- Verduci E, Mameli C, Amatruda M, Petitti A, Vizzuso S, El Assadi F, Zuccotti G, Alabduljabbar S, Terranegra A. Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota. Front Nutr. 2020;7 [Crossref]
148- Kaushik A, Sangtani R, Parmar H, Bala K. Algal metabolites: Paving the way towards new generation antidiabetic therapeutics. Algal Research. 2023;69:102904 [Crossref]
149- Karpov D, Sosnovtseva A, Pylina S, Bastrich A, Petrova D, Kovalev M, Shuvalova A, Eremkina A, Mokrysheva N. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”. IJMS. 2023;24(24):17320 [Crossref]
150- Mazur P, Savychuk N, Mazur I. The influence of type 1 diabetes on the hard dental tissues and the development of caries (literature review). Mìžnarodnij endokrinologìčnij žurnal. 2024;19(8):617 [Crossref]
151- Passanisi S, Pecoraro M, Pira F, Alibrandi A, Donia V, Lonia P, Pajno G, Salzano G, Lombardo F. Quarantine Due to the COVID-19 Pandemic From the Perspective of Pediatric Patients With Type 1 Diabetes: A Web-Based Survey. Front Pediatr. 2020;8 [Crossref]
152- Aberer F, Pieber T, Eckstein M, Sourij H, Moser O. Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective. Pharmaceutics. 2022;14(6):1180 [Crossref]
153- Rostoka E, Shvirksts K, Salna E, Trapina I, Fedulovs A, Grube M, Sokolovska J. Prediction of type 1 diabetes with machine learning algorithms based on FTIR spectral data in peripheral blood mononuclear cells. Anal Methods. 2023;15(37):4926 [Crossref]
154- Mehta J, Hiremath S, Chilimba C, Ghasemi A, Weaver J. Translation of cell therapies to treat autoimmune disorders. Advanced Drug Delivery Reviews. 2024;205:115161 [Crossref]
155- Schroeder A, Rosenkranz R, Yarrow L, Haub M, Rosenkranz S. Recovery Phase Nutrition and Insulin Strategies for a Collegiate Distance Runner with Type 1 Diabetes Mellitus: A Case Study. Sports. 2023;11(11):214 [Crossref]
156- Iheagwam F, Iheagwam O, Onuoha M, Ogunlana O, Chinedu S. Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats. Sci Rep. 2022;12(1) [Crossref]
157- Prapa I, Yanni A, Nikolaou A, Kostomitsopoulos N, Kalogeropoulos N, Bezirtzoglou E, Karathanos V, Kourkoutas Y. Dietary Pistachio (Pistacia vera L.) Beneficially Alters Fatty Acid Profiles in Streptozotocin-Induced Diabetic Rat. Applied Sciences. 2022;12(9):4606 [Crossref]
158- Lee S, Washburn D, Colwell B, Gwarzo I, Kellstedt D, Ahenda P, Maddock J. Examining social determinants of undiagnosed diabetes in Namibia and South Africa using a behavioral model of health services use. Diabetes Research and Clinical Practice. 2021;175:108814 [Crossref]
159- Popoviciu M, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S. Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine. JPM. 2023;13(3):422 [Crossref]
160- Conrad N, Misra S, Verbakel J, Verbeke G, Molenberghs G, Taylor P, Mason J, Sattar N, McMurray J, McInnes I, Khunti K, Cambridge G. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. The Lancet. 2023;401(10391):1878 [Crossref]
161- Almutairi F, Karlas T. The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers. PLoS ONE. 2024;19(6):e0303098 [Crossref]
162- Martemucci G, Portincasa P, Centonze V, Mariano M, Khalil M, D'Alessandro A. Prevention of Oxidative Stress and Diseases by Antioxidant Supplementation. MC. 2023;19(6):509 [Crossref]
163- Carulli E, Pompilio G, Vinci M. Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?. Cells. 2023;12(7):1054 [Crossref]
164- Matuszewski W, Gontarz-Nowak K, Harazny J, Bandurska-Stankiewicz E. Evaluation of Morphological Changes in Retinal Vessels in Type 1 Diabetes Mellitus Patients with the Use of Adaptive Optics. Biomedicines. 2022;10(8):1926 [Crossref]
165- Smith F, Sabri A, Heppel M, Fonseca I, Chowdhury F, Cheung K, Willmor S, Rawson F, Marlow M. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study. International Journal of Pharmaceutics. 2022;628:122234 [Crossref]
166- Resurrección D, Navas-Campaña D, Gutiérrez-Colosía M, Ibáñez-Alfonso J, Ruiz-Aranda D. Psychotherapeutic Interventions to Improve Psychological Adjustment in Type 1 Diabetes: A Systematic Review. IJERPH. 2021;18(20):10940 [Crossref]
167- Harding J, Wander P, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram R, Magliano D, Zhou Z, Jenkins A, Ma R. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. 2022;45(4):994 [Crossref]
168- Spaggiari M, Martinino A, Petrochenkov E, Bencini G, Zhang J, Cardoso V, Akshelyan S, Di Cocco P, Almario-Alvarez J, Tzvetanov I, Benedetti E. Single-center retrospective assessment of robotic-assisted simultaneous pancreas-kidney transplants: Exploring clinical utility. American Journal of Transplantation. 2024;24(6):1035 [Crossref]
169- Andreo-López M, Zarco-Martín M, Contreras-Bolívar V, Fernández-Soto M. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus. Nutrients. 2023;15(23):4914 [Crossref]
170- Passanisi S, Salzano G, Aloe M, Bombaci B, Citriniti F, De Berardinis F, De Marco R, Lazzaro N, Lia M, Lia R, Mammì F, Stamati F, Toscano R, Ventrici C, Iafusco D, Lombardo F. Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019–2021. Ital J Pediatr. 2022;48(1) [Crossref]
171- Rochmah N, Farahdina F, Deakandi W, Putri Q, Nuzula T, Fedora K, ‘Aina Q, Faizi M. The Role of Telemedicine in Type 1 Diabetes Children during COVID-19 Pandemic Era: A Systematic Review and Meta-analysis. Open Access Maced J Med Sci. 2023;11(F):38 [Crossref]
172- Tunku Zainudin T, Nachimuthu M, Ibrahim M. Outcome of Modified Pirogoff Amputation for Diabetic Foot Infection: A Single-Center Case Series. 2023; [Crossref]
173- Karpen S, Dunne J, Frohnert B, Marinac M, Richard C, David S, O’Doherty I. Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies. Diabetologia. 2023;66(3):415 [Crossref]
174- Grebe T, Khushf G, Greally J, Turley P, Foyouzi N, Rabin-Havt S, Berkman B, Pope K, Vatta M, Kaur S. Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2024;26(4):101052 [Crossref]
175- Zishan M, Mohamed M, Hossain C, Ahasan R, Sharun S. Design and Deployment of E-Health System Using Machine Learning in the Perspective of Developing Countries. 2022;13(1):1 [Crossref]
176- Bartolome A, Prioleau T. A computational framework for discovering digital biomarkers of glycemic control. npj Digit Med. 2022;5(1) [Crossref]
177- Podojil J, Genardi S, Chiang M, Kakade S, Neef T, Murthy T, Boyne M, Elhofy A, Miller S. Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice. 2022;209(3):465 [Crossref]
178- Chaves Y, Raymundi A, Waltrick A, de Souza Crippa J, Stern C, da Cunha J, Zanoveli J. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Acta Neuropsychiatr. 2023;:1 [Crossref]
179- Ozana V, Hruska K, Sechi L. Neglected Facts on Mycobacterium Avium Subspecies Paratuberculosis and Type 1 Diabetes. IJMS. 2022;23(7):3657 [Crossref]
180- Longo M, Scappaticcio L, Petrizzo M, Castaldo F, Sarnataro A, Forestiere D, Caiazzo F, Bellastella G, Maiorino M, Capuano A, Esposito K. Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring. J Endocrinol Invest. 2022;45(2):445 [Crossref]
181- Koprivica I, Jonić N, Diamantis D, Gajić D, Saksida T, Pejnović N, Tzakos A, Stojanović I. Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice. Life Sciences. 2022;288:120184 [Crossref]
182- Muammar T, Fojas E, Helal R, Lessan N. Ramadan Fasting Among Older Children and Adolescents With Type 1 Diabetes Mellitus: A Real-World Study From the UAE. Front Nutr. 2022;9 [Crossref]
183- Annuzzi G, Apicella A, Arpaia P, Bozzetto L, Criscuolo S, Benedetto E, Pesola M, Prevete R, Vallefuoco E. Impact of Nutritional Factors in Blood Glucose Prediction in Type 1 Diabetes Through Machine Learning. IEEE Access. 2023;11:17104 [Crossref]
184- Brenu E, Harris M, Hamilton-Williams E. Circulating biomarkers during progression to type 1 diabetes: A systematic review. Front Endocrinol. 2023;14 [Crossref]
185- Cisse A, Erber J, McHale B, Gato W. Hepatic genomic assessment of dietary ingestion of 2-aminoanthracene in Sprague Dawley rats. Journal of Environmental Science and Health, Part B. 2023;58(3):229 [Crossref]
186- Leishman D, Oppler S, Stone L, O’Brien T, Ramachandran S, Willenberg B, Adams A, Hering B, Graham M. Targeted mapping and utilization of the perihepatic surface for therapeutic beta cell replacement and retrieval in diabetic non-human primates. Front Transplant. 2024;3 [Crossref]
187- Edache E, Uzairu A, Mamza P, Shallangwa G, Ibrahim M. Design of some potent non-toxic autoimmune disorder inhibitors based on 2D-QSAR, CoMFA, molecular docking, and molecular dynamics investigations. Intelligent Pharmacy. 2024; [Crossref]
188- Alberti A, Schuelter-Trevisol F, Iser Betine P, Traebert E, Freiberger V, Ventura L, Rezin G, da Silva B, Meneghetti Dallacosta F, Grigollo L, Dias P, Fin G, De Jesus J, Pertille F, Rossoni C, Hur Soares B, Nodari Júnior R, Comim C. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken. WJCC. 2021;9(20):5358 [Crossref]
189- Ryan P, Zahradnik M, Konnyu K, Rader T, Halasy M, Shulman R, Ivers N, Hawkes C, Grimshaw J. Effectiveness of quality improvement strategies for type 1 diabetes in children and adolescents: a systematic review protocol. HRB Open Res. 2021;4:87 [Crossref]
190- Zhuravlyova L, Cherpita V. Determination of the relationship of visphatin and homocysteine levels with indicators of glucose metabolism and lipid metabolism in peri- and postmenopause women with type 2 diabetes mellitus and osteoarthritis. Eureka: HS. 2023;(1):34 [Crossref]
191- Díez-Manglano J, Asìn Samper U. Type-1 diabetes and pulmonary function tests. A meta-analysis. Respiratory Medicine. 2022;203:106991 [Crossref]
192- Alshurtan K, Alnizari O, Aldarwish H, Al-Tufaif A. Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis. 2022; [Crossref]
193- Johansen V, Færø D, Buschard K, Kristiansen K, Pociot F, Kiilerich P, Josefsen K, Haupt-Jorgensen M, Antvorskov J. A Gluten-Free Diet during Pregnancy and Early Life Increases Short Chain Fatty Acid-Producing Bacteria and Regulatory T Cells in Prediabetic NOD Mice. Cells. 2023;12(12):1567 [Crossref]
194- Ma Y, Law K, Hassan L, Nenadic G, van der Veer S. Experiences and Views of Young People and Health Care Professionals of Using Social Media to Self-Manage Type 1 Diabetes Mellitus: Thematic Synthesis of Qualitative Studies. JMIR Pediatr Parent. 2024;7:e56919 [Crossref]
195- Tran P, Kim E, Tran L, Khaled B, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed J, She J, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications. IJERPH. 2021;18(21):11094 [Crossref]
196- Fayyaz F, Mardi P, Sobhani S, Sokoty L, Aghamahdi F, Qorbani M. Association of quality of life with medication adherence and glycemic control in patients with type 1 diabetes. J Diabetes Metab Disord. 2023; [Crossref]
197- Ma J, Yan X, Feng Q, Liu W, Pérez Manghi F, García‐Hernández P, Wang G, Xu J, Yuan Y, Zhou Z. Ultra‐rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double‐blind phase 3 study. Diabetes Obesity Metabolism. 2024;26(1):311 [Crossref]
198- Titoria R, Amed S, Tang T. Peer Support Interventions on Digital Platforms for Children With Type 1 Diabetes and Their Caregivers. 2022;35(1):26 [Crossref]
199- Habteyohans B, Hailu B, Meseret F, Mohammed A, Berhanu Y, Alemu A, Tolosa G, Keneni M, Desalew A. Poor glycemic control and its associated factors among children with type 1 diabetes mellitus in Harar, eastern Ethiopia: A cross-sectional study. BMC Endocr Disord. 2023;23(1) [Crossref]
200- Root-Bernstein R, Chiles K, Huber J, Ziehl A, Turke M, Pietrowicz M. Clostridia and Enteroviruses as Synergistic Triggers of Type 1 Diabetes Mellitus. IJMS. 2023;24(9):8336 [Crossref]
201- Ojo O, Amanze J, Oni A, Grant S, Iyobhebhe M, Elebiyo T, Rotimi D, Asogwa N, Oyinloye B, Ajiboye B, Ojo A. Antidiabetic activity of avocado seeds (Persea americana Mill.) in diabetic rats via activation of PI3K/AKT signaling pathway. Sci Rep. 2022;12(1) [Crossref]
202- Suganthi K, Lalvani N, Jevalikar G, Sarda A, Unnikrishnan A. A practical approach to the diagnosis of type 1 diabetes: An Indian perspective. Chron Diabetes Res Pract. 2023;2(2):73 [Crossref]
203- Elkomy N, El-Shaibany A, Elnagar G, Abdelkhalek A, Al-Mahbashi H, Elaasser M, Raweh S, Aldiyarbi M, Raslan A. Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract. Journal of Ethnopharmacology. 2023;309:116310 [Crossref]
204- Russell W, Bundy B, Anderson M, Cooney L, Gitelman S, Goland R, Gottlieb P, Greenbaum C, Haller M, Krischer J, Libman I, Linsley P, Long S, Lord S, Moore D, Moore W, Moran A, Muir A, Raskin P, Skyler J, Wentworth J, Wherrett D, Wilson D, Ziegler A, Herold K. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. 2023;46(5):1005 [Crossref]
205- Marcus C, Danielsson P, Hagman E. Pediatric obesity—Long‐term consequences and effect of weight loss. J Intern Med. 2022;292(6):870 [Crossref]
206- Jebraeili H, Shabbidar S, Sajjadpour Z, Aghdam S, Qorbani M, Rajab A, Sotoudeh G. The association between carbohydrate quality index and anthropometry, blood glucose, lipid profile and blood pressure in people with type 1 diabetes mellitus: a cross-sectional study in Iran. J Diabetes Metab Disord. 2021;20(2):1349 [Crossref]
207- Bhuiyan S, Badran H. The Impact of COVID‐19 Pandemic on Diabetic Children: A Systematic Review on the Current Evidence. IJCMHE. 2020;:1 [Crossref]
208- Biskupiak J, Ramos M, Levy C, Forlenza G, Hopley C, Boyd J, Swift D, Lamotte M, Brixner D. Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. JMCP. 2023;29(7):807 [Crossref]
209- Vergès B. Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data. Atherosclerosis. 2024;394:117158 [Crossref]
210- Liao W, Huang Y, Chang Y, Liu T, Lu H, Tiao Z, Su P, Wang C, Tsai F. Combining polygenic risk scores and human leukocyte antigen variants for personalized risk assessment of type 1 diabetes in the Taiwanese population. Diabetes Obesity Metabolism. 2023;25(10):2928 [Crossref]
211- Pintaudi B, Nani A, Gironi I, Bertuzzi F. Advanced technology for type 1 diabetes care in a deaf-mute patient. BMJ Case Rep. 2022;15(1):e245336 [Crossref]
212- Gómez-Peralta F, Menéndez E, Conde S, Abellán-Galiana P, Brito M, Beléndez M, Pérez A. Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study. JCM. 2024;13(7):1922 [Crossref]
213- Sgrazzutti L, Sansone F, Attanasi M, Di Pillo S, Chiarelli F. Coaggregation of Asthma and Type 1 Diabetes in Children: A Narrative Review. IJMS. 2021;22(11):5757 [Crossref]
214- Lee G, Lee C, Kim S. Association of advanced chronic kidney disease with diabetic retinopathy severity in older patients with diabetes: a retrospective cross-sectional study. JYMS. 2023;40(2):146 [Crossref]
215- Yen P, Young A. Review of Modern Insulin Pumps and the Perioperative Management of the Type 1 Diabetic Patient for Ambulatory Dental Surgery. 2021;68(3):180 [Crossref]
216- Raicevic M, Samardzic M, Soldatovic I, Curovic Popovic N, Vukovic R. Trends in nationwide incidence of pediatric type 1 diabetes in Montenegro during the last 30 years. Front Endocrinol. 2022;13 [Crossref]
217- Al-Mulla F, Alhomaidah D, Abu-Farha M, Hasan A, Al-Khairi I, Nizam R, Alqabandi R, Alkandari H, Abubaker J. Early autoantibody screening for type 1 diabetes: a Kuwaiti perspective on the advantages of multiplexing chemiluminescent assays. Front Immunol. 2023;14 [Crossref]
218- Sinthuprasith P, Wejaphikul K, Puttawong D, Tang-Ngam H, Sanrattana N, Unachak K, Dejkhamron P. Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic. 2024;37(6):487 [Crossref]
219- Dubey S, Chiao J. Implantable Radio Frequency Powered Gastric Electrical Stimulator. IEEE J Electromagn RF Microw Med Biol. 2022;6(3):340 [Crossref]
220- Zhang S, Staples A. Microfluidic-based systems for the management of diabetes. Drug Deliv and Transl Res. 2024; [Crossref]
221- ELMAOĞULLARI S, YİLDİRİM N, SAVAŞ ERDEVE Ş, AYCAN Z, ÇETİNKAYA S. 2015-2019 yılları arasında çocuk endokrinoloji servisine yatırılmış diyabetes mellitus tanılı olguların yatış durumlarının değerlendirilmesi. 2021;12(3):334 [Crossref]
222- Liu S, Larsson H, Lichtenstein P, Ludvigsson J, Gudbjörnsdottir S, Serlachius E, Kuja‐Halkola R, Butwicka A. Childhood‐onset type 1 diabetes and attention‐deficit/hyperactivity disorder with educational attainment: A population‐based sibling‐comparison study. Acta Paediatrica. 2022;111(11):2131 [Crossref]
223- Irilouzadian R, Afaghi S, Esmaeili Tarki F, Rahimi F, Malekpour Alamadari N. Urinary c‐peptide creatinine ratio (UCPCR) as a predictor of coronary artery disease in type 1 diabetes mellitus. Endocrino Diabet & Metabol. 2023;6(3) [Crossref]
224- Zulhisham M, Suhaimi H, Shatriah I. Central Corneal Thickness and Intraocular Pressure in Children with Type 1 Diabetes Mellitus. Korean J Ophthalmol. 2023;37(6):462 [Crossref]
225- Alkhuder K. Fourier-transform infrared spectroscopy: A universal optical sensing technique with auspicious application prospects in the diagnosis and management of autoimmune diseases. Photodiagnosis and Photodynamic Therapy. 2023;42:103606 [Crossref]
226- Ventelä J, Alanko A, Auvinen A, Lohi O, Nikkilä A. Dual direction associations between common autoimmune diseases and leukemia among children and young adults: A systematic review. Cancer Epidemiology. 2023;86:102411 [Crossref]
227- Glover K, Mishra D, Singh T. Epidemiology of Ocular Manifestations in Autoimmune Disease. Front Immunol. 2021;12 [Crossref]
228- Khalil R, Abdel-Moneim A, Arafa A, Allam G, El-Senousy W, Mabrouk D. Possible association of rotavirus IgG with cytokine expression levels and dyslipidemia in rotavirus-infected type 1 diabetic children. Mol Biol Rep. 2022;49(8):7587 [Crossref]
229- Schwartz X, Porter B, Gilbert M, Sullivan A, Long B, Lentz S. Emergency Department Management of Uncomplicated Hyperglycemia in Patients without History of Diabetes. The Journal of Emergency Medicine. 2023;65(2):e81 [Crossref]
230- Shen R, Guo X, Zou T, Ma L. Reply to Siyu Tan: Associations of cardiovascular health assessed by life’s essential 8 with diabetic retinopathy and mortality in type 2 diabetes. The author’s reply. Primary Care Diabetes. 2023;17(6):669 [Crossref]
231- Azimi N, Ozgoli G, Ebadi A, Majd H, Rajab A, Kiani Z, Bazzazian S, Mokhtaryan-Gilani T. Development and psychometric assessment of the sexual-reproductive health profile of women with type-1 diabetes mellitus. BMC Public Health. 2022;22(1) [Crossref]
232- Corsenac P, Parent M, Mansaray H, Benedetti A, Richard H, Stäger S, Rousseau M. Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood. Diabetes & Metabolism. 2022;48(3):101337 [Crossref]
233- Perfect M, Silva G, Chin C, Wheeler M, Frye S, Mullins V, Quan S. Extending sleep to improve glycemia: The Family Routines Enhancing Adolescent Diabetes by Optimizing Management (FREADOM) randomized clinical trial protocol. Contemporary Clinical Trials. 2023;124:106929 [Crossref]
234- Luo C, Hou C, Yang D, Tan T, Chao C. Urolithin C alleviates pancreatic β-cell dysfunction in type 1 diabetes by activating Nrf2 signaling. Nutr Diabetes. 2023;13(1) [Crossref]
235- Tsai D, Flores Garcia J, Fogel J, Wee C, Reid M, Raymond J. Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes. J Diabetes Sci Technol. 2022;16(4):834 [Crossref]
236- Alassaf A, Gharaibeh L, Abuna’meh L, Odeh R. Adequacy of knowledge of new medical graduates about diagnosis and management of children and adolescents with type 1 diabetes in a developing country. BMC Med Educ. 2023;23(1) [Crossref]
237- Rojas M, Heuer L, Zhang W, Chen Y, Ridgway W. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes. Front Immunol. 2022;13 [Crossref]
238- Makam A, Biswas A, Kothegala L, Gandasi N. Setting the Stage for Insulin Granule Dysfunction during Type-1-Diabetes: Is ER Stress the Culprit?. Biomedicines. 2022;10(11):2695 [Crossref]
239- Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago E, Amitay E, Brenner H, Buchanan D, Campbell P, Cao Y, Chan A, Chang‐Claude J, Drew D, Figueiredo J, French A, Gallinger S, Giannakis M, Giles G, Gunter M, Hoffmeister M, Hsu L, Jenkins M, Lin Y, Moreno V, Murphy N, Newcomb P, Newton C, Nowak J, Obón‐Santacana M, Ogino S, Potter J, Song M, Steinfelder R, Sun W, Thibodeau S, Toland A, Ugai T, Um C, Woods M, Phipps A, Harrison T, Peters U. Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases. Intl Journal of Cancer. 2022;151(3):348 [Crossref]
240- Chapman P, Aas A, Bjerkan K, Garnweidner-Holme L. Experiences of follow-up and dietary guidance among young adults diagnosed with type 1 diabetes as children: a qualitative study. NTFE. 2023;21(3):2 [Crossref]
241- Pauley M, Henscheid N, David S, Karpen S, Romero K, Podichetty J. T1dCteGui: A User‐Friendly Clinical Trial Enrichment Tool to Optimize T1D Prevention Studies by Leveraging AI/ML Based Synthetic Patient Population. Clin Pharma and Therapeutics. 2023;114(3):704 [Crossref]
242- Gardener L, Desha L, Bourke-Taylor H, Srinivasan K. Developing Self-Management of Type 1 Diabetes in the Australian School Setting: Perspectives of Adolescent Involvement in Sharing Responsibility for Diabetes Management. Health & Social Care in the Community. 2023;2023:1 [Crossref]
243- Massarenti L, Aniol-Nielsen C, Enevold C, Toft-Hansen H, Nielsen C. Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus. IJMS. 2022;23(12):6481 [Crossref]
244- Bowden N, Dixon R, Anderson V, de Bock M, Boucsein A, Kewene-Edwards M, Gibb S, Kokaua J, Palmer O, Paul R, Taylor B, Vu H, Wheeler B. Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure. Diabetologia. 2024;67(1):62 [Crossref]
245- Rakhmawati H, Wungu C, Purwanto B, Andarianto A. Exercise under hypoxia on glucose tolerance in type 2 diabetes mellitus risk individuals: A systematic review and meta-analysis. 2024;36(2):212 [Crossref]
246- Martínez-Ortega A, Muñoz-Gómez C, Gros-Herguido N, Remón-Ruiz P, Acosta-Delgado D, Losada-Viñau F, Pumar-López A, Mangas-Cruz M, González-Navarro I, López-Gallardo G, Bellido V, Soto-Moreno A. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia. JCM. 2022;11(4):1039 [Crossref]
247- Bikulčienė I, Baleišis J, Mazgelytė E, Rudys R, Vosyliūtė R, Šimkūnaitė-Rizgelienė R, Kaminskas A, Karčiauskaitė D. Impact of chronic psychological stress on platelet membrane fatty acid composition in a rat model of type 1 diabetes Mellitus. Lipids Health Dis. 2024;23(1) [Crossref]
248- Thornton L. Zinc transporter 8 antibody-mediated type 1 diabetes mellitus. 2022;47(8):6 [Crossref]
249- Ganesh R, Meenakshi B. Serum Zinc and Copper Levels in Children with Type 1 Diabetes Mellitus. Indian J Pediatr. 2023;90(10):1052 [Crossref]
250- Tatsiopoulou P, Porfyri G, Bonti E, Diakogiannis I. Priorities in the Interdisciplinary Approach of Specific Learning Disorders (SLD) in Children with Type I Diabetes Mellitus (T1DM). From Theory to Practice. Brain Sciences. 2020;11(1):4 [Crossref]
251- Ross C, Ward Z, Gomber A, Owais M, Yeh J, Reddy C, Atun R. The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review. Front Endocrinol. 2022;13 [Crossref]
252- Offerni J, Ai Li E, Rasmussen A, Xie W, Levine M, Murkin J, McAlister V, Luke P, Sener A. A Prospective Study of the Effect of Gastroduodenal Artery Reconstruction on Duodenal Oxygenation and Enzyme Content After Pancreas Transplantation. World j surg. 2023;47(11):2846 [Crossref]
253- Weston C, Boehm B, Pozzilli P. Type 1 diabetes: A new vision of the disease based on endotypes. Diabetes Metabolism Res. 2024;40(2) [Crossref]
254- Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A, Serrano Olmedo I, Tinahones F, Carral San Laureano F, López de la Torre M, Moreno Carazo A, Acha J, Bandrés O, Masmiquel L, Payeras F, Gómez I, Bayo J, Montalbán C, de Luis D, Díaz-Soto G, López-Guzmán A, Santos-Mazo E, López Jiménez L, Alvarez V, Blanco Samper B, Chico A, Dalama B, Pérez-Maraver M, Soldevila B, Capel Flores I, Hernández García M, Ricart W, Megia Colet A, Climent Biescas E, Ampudia-Blasco F, Hernández-Mijares A, Sánchez-Juan C, Picó A, Domínguez Escribano J, Fajardo C, Pedro T, Abellán P, Rossetti P, Morales-Pérez F, Enciso F, Soto González A, Bellido D, Luna Cano R, García López J, Andía V, Arranz Martín J, Azriel S, Botella Serrano M, Brito Sanfiel M, Calle Pascual A, del Cañizo Gómez F, Gargallo Fernández M, Illán F, Hernández Martínez A, Forga Llenas L, Gaztambide S, Fuentes Gómez C, Oleaga A, Martínez de Salinas M, López-Siguero J, Gómez-Gila A, Lechuga Sancho A, Ferrer Lozano M, Riaño Galán I, Caimari M, Cardona R, Clemente León M, Carreras González G, Diez F, Rodríguez P, Roldán B, González Pérez del Villar N, Ros Pérez P, Rica I, Diez López I. Physical activity patterns in type 1 diabetes in Spain: The SED1 study. BMC Sports Sci Med Rehabil. 2023;15(1) [Crossref]
255- Jones J, James S, Brown F, O'Neal D, I Ekinci E. Dead in bed – A systematic review of overnight deaths in type 1 diabetes. Diabetes Research and Clinical Practice. 2022;191:110042 [Crossref]
256- Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B, Fasching P, Winhofer Y, Kautzky-Willer A, Schernthaner G, Prager R, Wascher T, Clodi M. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023). Wien Klin Wochenschr. 2023;135(S1):98 [Crossref]
257- Kinney M, You L, Sims E, Wherrett D, Schatz D, Lord S, Krischer J, Russell W, Gottlieb P, Libman I, Buckner J, DiMeglio L, Herold K, Steck A. Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials. 2023;7(3) [Crossref]
258- Sankofi B, Valencia-Rincón E, Sekhri M, Ponton-Almodovar A, Bernard J, Wellberg E. The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism. Front Endocrinol. 2023;14 [Crossref]
259- Rasmussen V, Thrysøe M, Nyengaard J, Tankisi H, Karlsson P, Hansen J, Krogh K, Brock C, Kamperis K, Madsen M, Singer W, Vestergaard E, Kristensen K, Terkelsen A. Neuropathy in adolescents with type 1 diabetes: Confirmatory diagnostic tests, bedside tests, and risk factors. Diabetes Research and Clinical Practice. 2023;201:110736 [Crossref]
260- Berlanga-Acosta J, Garcia-Ojalvo A, Guillen-Nieto G, Ayala-Avila M. Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections. IJMS. 2023;24(12):10170 [Crossref]
261- Cannataro R, Cione E, Cerullo G, Rondanelli M, Micheletti P, Crisafulli O, Micheli M, D'Antona G. Type 1 diabetes management in a competitive athlete: A five‐year case report. Physiological Reports. 2023;11(13) [Crossref]
262- Granados A, Carrillo Iregui A. Type 1 Diabetes Management in the Hospital Setting. 2024;45(4):201 [Crossref]
263- Gutaj P, Matysiak J, Matuszewska E, Jaskiewicz K, Kamińska D, Światły-Błaszkiewicz A, Szczapa T, Kalantarova A, Gajecka M, Wender-Ozegowska E. Maternal serum proteomic profiles of pregnant women with type 1 diabetes. Sci Rep. 2022;12(1) [Crossref]
264- Khorshidi M, Sayyari A, Aryaeian N, Olang B, Alaei M, Khalili M, Hosseini A, Salehi M. Effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A randomized clinical trial. Front Nutr. 2022;9 [Crossref]
265- Poh Shean W, Chin Voon T, Long Bidin M, Adam N. Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes. Journal of the Royal College of Physicians of Edinburgh. 2023;53(2):94 [Crossref]
266- Tornese G, Greco L. Screening per diabete mellito tipo 1 e celiachia: intenzioni, pregi e difetti. 2024;43(4):243 [Crossref]
267- Rodrigues Oliveira S, Rebocho A, Ahmadpour E, Nissapatorn V, de Lourdes Pereira M. Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices. Micromachines. 2023;14(1):151 [Crossref]
268- Nekoua M, Mercier A, Alhazmi A, Sane F, Alidjinou E, Hober D. Fighting Enteroviral Infections to Prevent Type 1 Diabetes. Microorganisms. 2022;10(4):768 [Crossref]
269- Ho B, Teo A, Ng N. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation. Front Immunol. 2024;15 [Crossref]
270- Ma H, Murphy C, Loscher C, O’Kennedy R. Autoantibodies - enemies, and/or potential allies?. Front Immunol. 2022;13 [Crossref]
271- Raghav A, Ashraf H, Jeong G. Engineered Extracellular Vesicles in Treatment of Type 1 Diabetes Mellitus: A Prospective Review. Biomedicines. 2022;10(12):3042 [Crossref]
272- Nelson C, Dzakpasu S, Moore A, Darling E, Edwards W, Murphy P, Scott H, Van Den Hof M, Ray J. Diabetes mellitus in pregnancy across Canada. BMC Pregnancy Childbirth. 2024;24(1) [Crossref]
273- Boutari C, Pappas P, Theodoridis T, Vavilis D. Humanin and diabetes mellitus: A review of in vitro and in vivo studies. WJD. 2022;13(3):213 [Crossref]
274- Liu Y, Yu Q, Ye L, Yang L, Cui Y. A wearable, minimally-invasive, fully electrochemically-controlled feedback minisystem for diabetes management. Lab Chip. 2023;23(3):421 [Crossref]
275- Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler J, Snoek F, Weinstock R, Peters A. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 2021;44(11):2589 [Crossref]
276- Miller F. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Current Opinion in Immunology. 2023;80:102266 [Crossref]
277- Parmar C, Appel S, Lee L, Ribeiro R, Sakran N, Pouwels S. Choice of Bariatric Surgery in Patients with Obesity and Type 1 Diabetes Mellitus? an Up-to-Date Systematic Review. OBES SURG. 2022;32(12):3992 [Crossref]
278- Zafra‐Tanaka J, del Valle A, Bernabé‐Ortiz A, Miranda J, Beran D. Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review. Diabet Med. 2024;41(2) [Crossref]
279- Paez-Mayorga J, Lukin I, Emerich D, de Vos P, Orive G, Grattoni A. Emerging strategies for beta cell transplantation to treat diabetes. Trends in Pharmacological Sciences. 2022;43(3):221 [Crossref]
280- Madigan S, Korczak D. Is It Time to Reconsider the Diagnostic Construct Validity of Depressive Disorders for Young Children?. JAMA Pediatr. 2023;177(10):1008 [Crossref]
281- de Jongh D, Thom R, Cronin A, Bunnik E, Massey E. Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and Psychosocial Interdisciplinary Considerations and Key Recommendations. Transpl Int. 2023;36 [Crossref]
282- Bloomgarden Z. Biosimilar insulin concepts. Journal of Diabetes. 2022;14(4):231 [Crossref]
283- Ullah S, Zheng Z, Rahman W, Ullah F, Ullah A, Iqbal M, Iqbal N, Gao T, Istifli E. A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids. PLoS ONE. 2023;18(8):e0290576 [Crossref]
284- Edwards M, Kudzinskas A, Alazawi A, Hughes W, Goodall R, Harbinson E, Salciccioli J, Marshall D, Shalhoub J. Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019. Diabetes and Vascular Disease Research. 2023;20(6) [Crossref]
285- Charoenpiriya A, Chailurkit L, Ongphiphadhanakul B. Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes. BMC Endocr Disord. 2022;22(1) [Crossref]
286- Chávez J, Wijaya K, Pinto C, Burgos-Simón C. A model for type I diabetes in an HIV-infected patient under highly active antiretroviral therapy. Chaos, Solitons & Fractals. 2022;155:111716 [Crossref]
287- Ghosh A, Sanyal A, Mallick A. Recent advances in the development of bioartificial pancreas using 3D bioprinting for the treatment of type 1 diabetes: a review. 2023;:886 [Crossref]
288- Lieu F, Martin W, Birt S, Mattes J, McGee R. Development of a Multivariable Risk Prediction Tool to Predict Adverse Outcomes among Children with Type 1 Diabetes: A Pilot Study. Pediatric Diabetes. 2024;2024:1 [Crossref]
289- Rigo F. Left ventricular diastolic dysfunction in type 1 diabetes mellitus: the importance of being earlier. Int J Cardiovasc Imaging. 2022;38(9):1999 [Crossref]
290- Shubow S, Sun Q, Nguyen Phan A, Hammell D, Kane M, Lyman G, Gibofsky A, Lichtenstein G, Bloomgarden Z, Cross R, Yim S, Polli J, Wang Y. Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. Clin Pharma and Therapeutics. 2023;113(1):37 [Crossref]
291- Sittadjody S, Opara E. Encapsulation Strategies for Pancreatic Islet Transplantation without Immune Suppression. Curr Stem Cell Rep. 2021;7(2):49 [Crossref]
292- Zainal Abidin Z, Noor E, Mohd Nor N, Mohamed Nazari N, Anuar Zaini A, Azizi N, Soelar S, Shahrizad M, Abdul Halim R. Type 1 Diabetes Mellitus Patients' Self-perception of Periodontal Diseases. Eur J Dent. 2024;18(02):534 [Crossref]
293- Traversi D, Scaioli G, Rabbone I, Carletto G, Ferro A, Franchitti E, Carrera D, Savastio S, Cadario F, Siliquini R, Cerutti F, Durazzo M. Gut microbiota, behavior, and nutrition after type 1 diabetes diagnosis: A longitudinal study for supporting data in the metabolic control. Front Nutr. 2022;9 [Crossref]
294- Almeida L, Münzer S, Kühl T. More personal, but not better: The personalization effect in learning neutral and aversive health information. Computer Assisted Learning. 2024; [Crossref]
295- Quinn L, Wong F, Narendran P. Environmental Determinants of Type 1 Diabetes: From Association to Proving Causality. Front Immunol. 2021;12 [Crossref]
296- Kharbikar B, Mohindra P, Desai T. Biomaterials to enhance stem cell transplantation. Cell Stem Cell. 2022;29(5):692 [Crossref]
297- Senbanjo I, Akinola I, Umar U, Anyabolu C, Abolurin O, Adekoya A, Adeniyi O, Adepoju A, Salisu M, Gwarzo G, Olorunmoteni O, Ugowe O, Suwaid S, Ashubu O, Fetuga M, Oduwole A. Children and adolescents with type 1 diabetes mellitus in Nigeria: clinical characteristics and compliance with care. 2022;35(11):1377 [Crossref]
298- Liu J, Yang Y, Qi Y. Efficacy of mesenchymal stromal cells in the treatment of type 1 diabetes: a systematic review. Cell Tissue Bank. 2024;25(2):663 [Crossref]
299- Fathi A, Babaei S, Babaei S, Baazm M, Sakhaie H, Babaei S. Effect of bromelain on mast cell numbers and degranulation in diabetic rat wound healing. J Wound Care. 2022;31(Sup8):S4 [Crossref]
300- Soares M, de Aquino P, Costa T, Serpa C, Chaves O. Insights into the effect of glucose on the binding between human serum albumin and the nonsteroidal anti-inflammatory drug nimesulide. International Journal of Biological Macromolecules. 2024;265:131148 [Crossref]
301- Cisuelo O, Stokes K, Oronti I, Haleem M, Barber T, Weickert M, Pecchia L, Hattersley J. Development of an artificial intelligence system to identify hypoglycaemia via ECG in adults with type 1 diabetes: protocol for data collection under controlled and free-living conditions. BMJ Open. 2023;13(4):e067899 [Crossref]
302- Mushcab H, Alsharif F, Nazeer A, Mollah A, Matroud A, Qahtani S, Ghamdi M. Tawazon- An Intensive Lifestyle Diabetes Prevention Program: The Saudi Arabian Pilot. JMDH. 2021;Volume 14:2767 [Crossref]
303- Skoufa L, Makri E, Barkoukis V, Papagianni M, Triantafyllou P, Kouidi E. Effects of a Diabetes Sports Summer Camp on the Levels of Physical Activity and Dimensions of Health-Related Quality of Life in Young Patients with Diabetes Mellitus Type 1: A Randomized Controlled Trial. Children. 2023;10(3):456 [Crossref]
304- Du C, Whiddett R, Buckle I, Chen C, Forbes J, Fotheringham A. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells. 2022;11(21):3503 [Crossref]
305- Minasian V, Nazari M. The association between type 1 diabetes and exercise/physical activity and prolongation of the honeymoon phase in patients. Life Sciences. 2023;332:122114 [Crossref]
306- Hsu T, Chen M, Bai Y, Chang W, Cheng C, Su T, Chen T, Tsai S, Liang C. Family coaggregation of type 1 diabetes mellitus, major depressive disorder, attention-deficiency hyperactivity disorder and autism spectrum disorder in affected families: a nationwide study. Acta Diabetol. 2023;60(4):517 [Crossref]
307- Chiang Y, Chang C, Yu H, Tsay P, Lo F, Chen C, Lin W, Hsu C, An C, Moons P. Developing the “Healthcare CEO App” for patients with type 1 diabetes transitioning from adolescence to young adulthood: A mixed‐methods study. Nursing Open. 2023;10(3):1755 [Crossref]
308- Ding Q, Sun B, Wang M, Li T, Li H, Han Q, Liao J, Tang Z. N-acetylcysteine alleviates oxidative stress and apoptosis and prevents skeletal muscle atrophy in type 1 diabetes mellitus through the NRF2/HO-1 pathway. Life Sciences. 2023;329:121975 [Crossref]
309- Dial A, Monaco C, Grafham G, Patel T, Tarnopolsky M, Hawke T. Impaired Function and Altered Morphology in the Skeletal Muscles of Adult Men and Women With Type 1 Diabetes. 2021;106(8):2405 [Crossref]
310- Montt-Blanchard D, Dubois-Camacho K, Costa-Cordella S, Sánchez R. Domesticating the condition: Design lessons gained from a marathon on how to cope with barriers imposed by type 1 diabetes. Front Psychol. 2022;13 [Crossref]
311- Finch L, Hawkley L, Schumm L, Iveniuk J, McClintock M, Huang E. Moderation of associations between weight discrimination and diabetes status by psychosocial factors. J Behav Med. 2024;47(2):244 [Crossref]
312- Ganasegeran K, Hor C, Jamil M, Suppiah P, Noor J, Hamid N, Chuan D, Manaf M, Ch’ng A, Looi I. Mapping the Scientific Landscape of Diabetes Research in Malaysia (2000–2018): A Systematic Scientometrics Study. IJERPH. 2021;18(1):318 [Crossref]
313- Nobs S, Kolodziejczyk A, Adler L, Horesh N, Botscharnikow C, Herzog E, Mohapatra G, Hejndorf S, Hodgetts R, Spivak I, Schorr L, Fluhr L, Kviatcovsky D, Zacharia A, Njuki S, Barasch D, Stettner N, Dori-Bachash M, Harmelin A, Brandis A, Mehlman T, Erez A, He Y, Ferrini S, Puschhof J, Shapiro H, Kopf M, Moussaieff A, Abdeen S, Elinav E. Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes. Nature. 2023;624(7992):645 [Crossref]
314- Roy S, Keshri U, Alam M, Wasnik A. Effect of Immunotherapy on C-peptide Levels in Patients With Type I Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. 2024; [Crossref]
315- Lin Y, Richardson C, Dobrin I, Pop-Busui R, Piatt G, Piette J. Accessibility and Openness to Diabetes Management Support With Mobile Phones: Survey Study of People With Type 1 Diabetes Using Advanced Diabetes Technologies. JMIR Diabetes. 2022;7(2):e36140 [Crossref]
316- Morales J, Muse R, Podichetty J, Burton J, David S, Lang P, Schmidt S, Romero K, O'Doherty I, Martin F, Campbell‐Thompson M, Haller M, Atkinson M, Kim S. Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies. CPT Pharmacom & Syst Pharma. 2023;12(7):1016 [Crossref]
317- Mistry S, Riches N, Gouripeddi R, Facelli J. Environmental exposures in machine learning and data mining approaches to diabetes etiology: A scoping review. Artificial Intelligence in Medicine. 2023;135:102461 [Crossref]
318- Lernmark Å, Akolkar B, Hagopian W, Krischer J, McIndoe R, Rewers M, Toppari J, Vehik K, Ziegler A. Possible heterogeneity of initial pancreatic islet beta‐cell autoimmunity heralding type 1 diabetes. J Intern Med. 2023;294(2):145 [Crossref]
319- Perumal N, Padidela R. Bone health assessment in children with type 1 diabetes using dual-energy X-ray absorptiometry scans: What is known and the way forward. JPED. 2022;2:4 [Crossref]
320- Ferizi L, Bimbashi V, Kelmendi J. Association between metabolic control and oral health in children with type 1 diabetes mellitus. BMC Oral Health. 2022;22(1) [Crossref]
321- Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler J, Snoek F, Weinstock R, Peters A. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609 [Crossref]
322- Begjani J, Hosseini A, Saneifard H, Hasanabad V. Social learning-based health literacy promotion on the self efficacy and social anxiety of adolescents with type 1 diabetes. Clin Diabetes Endocrinol. 2024;10(1) [Crossref]
323- M, Zhou Y, Takagi T, Tian Y. Safety, efficacy, and cost-effectiveness of insulin degludec U100 versus insulin glargine U300 in adults with type 1 diabetes: a systematic review and indirect treatment comparison. Int J Clin Pharm. 2022;44(3):587 [Crossref]
324- Ogrotis I, Koufakis T, Kotsa K. Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities. Medicina. 2023;59(4):668 [Crossref]
325- Frommer L, Kahaly G. Type 1 Diabetes and Autoimmune Thyroid Disease—The Genetic Link. Front Endocrinol. 2021;12 [Crossref]
326- De Maria M, Fabrizi D, Luciani M, Caruso R, Di Mauro S, Riegel B, Barbaranelli C, Ausili D. Further Evidence of Psychometric Performance of the Self-care of Diabetes Inventory in Adults With Type 1 and Type 2 Diabetes. 2022;56(6):632 [Crossref]
327- Alsahli M, Alalwan A, Aburisheh K, Alarifi F, Alshaya H, Alkholaif A, Shadid A, Alsahli S, Alsahly A, Alkhalifah M. Assessing satisfaction, quality of life, and HbA1c changes in type 1 diabetes patients who are using freestyle libre glucose monitoring. 2024;13(6):2367 [Crossref]
328- Jawale S. Intrapancreatic autologous stem cell therapy for type 1 diabetes – an experimental study. 2023;85(9):4355 [Crossref]
329- Furthner D, Lukas A, Schneider A, Mörwald K, Maruszczak K, Gombos P, Gomahr J, Steigleder-Schweiger C, Weghuber D, Pixner T. The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps. Nutrients. 2021;13(10):3558 [Crossref]
330- Ibrahim M, Parveen B, Zahiruddin S, Gautam G, Parveen R, Khan M, Gupta A, Ahmad S. Analysis of polyphenols in Aegle marmelos leaf and ameliorative efficacy against diabetic mice through restoration of antioxidant and anti‐inflammatory status . Journal of Food Biochemistry. 2022;46(4) [Crossref]
331- Kumar N, Patiyal S, Choudhury S, Tomer R, Dhall A, Raghava G. DMPPred: a tool for identification of antigenic regions responsible for inducing type 1 diabetes mellitus. 2023;24(1) [Crossref]
332- Battelino T, Danne T, Edelman S, Choudhary P, Renard E, Westerbacka J, Mukherjee B, Pilorget V, Coudert M, Bergenstal R. Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial. Diabetes Obesity Metabolism. 2023;25(2):545 [Crossref]
333- Yaribeygi H, Hemmati M, Nasimi F, Maleki M, Jamialahmadi T, Reiner I, Reiner Ž, Sahebkar A. Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats. JCM. 2023;12(11):3815 [Crossref]
334- Oppler S, Hocum Stone L, Leishman D, Janecek J, Moore M, Rangarajan P, Willenberg B, O’Brien T, Modiano J, Pheil N, Dalton J, Dalton M, Ramachandran S, Graham M. A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression. Sci Adv. 2024;10(1) [Crossref]
335- Galosi E, Hu X, Michael N, Nyengaard J, Truini A, Karlsson P. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review. Acta Diabetol. 2022;59(1):1 [Crossref]
336- Herance J, Ciudin A, Lamas-Domingo R, Aparicio-Gómez C, Hernández C, Simó R, Palomino-Schätzlein M. The Footprint of Type 1 Diabetes on Red Blood Cells: A Metabolomic and Lipidomic Study. JCM. 2023;12(2):556 [Crossref]
337- Ali Sherazi B, Läer S, Hasanbegovic S, Obarcanin E. Evaluating usability of and satisfaction with mHealth app in rural and remote areas—Germany GIZ collaboration in Bosnia-Herzegovina to optimize type 1 diabetes care. Front Digit Health. 2024;6 [Crossref]
338- Bucsa C, Farcas A, Iaru I, Mogosan C, Rusu A. Drug utilisation study of antidiabetic medication during 2012‐2019 in Romania. Int J Clin Pract. 2021;75(11) [Crossref]
339- Redondo M, Morgan N. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol. 2023;19(9):542 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission